Relative Effectiveness of Schizophrenia Therapy Study
Completed
- Conditions
- SchizophreniaBipolar Disorder
- Interventions
- Genetic: SULT4A1-1 genetic test
- First Posted Date
- 2010-11-22
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- Medco Health Solutions, Inc.
- Target Recruit Count
- 1110
- Registration Number
- NCT01245348
- Locations
- 🇺🇸
Medco Health Solutions, Inc., Franklin Lakes, New Jersey, United States
Additional KIF6 Risk Offers Better Adherence to Statins
Completed
- Conditions
- Cardiovascular DiseasesDyslipidemia
- Interventions
- Genetic: KIF6 genetic test
- First Posted Date
- 2010-02-15
- Last Posted Date
- 2012-02-01
- Lead Sponsor
- Medco Health Solutions, Inc.
- Target Recruit Count
- 1282
- Registration Number
- NCT01068834
- Locations
- 🇺🇸
Medco Health Solutions, Inc, Franklin Lakes, New Jersey, United States
Coventry Outcomes Study of Seniors (COSS): A Comparative Effectiveness Study to Evaluate the Effect of a Multidisciplinary Team's Intervention on the Incidence of Nonelective Hospitalizations in a Medicare Population
Not Applicable
Terminated
- Conditions
- Heart FailureChronic Obstructive Pulmonary DiseaseCardiovascular DiseaseDiabetesOsteoporosis
- Interventions
- Other: Usual case management and pharmacy management as provided by the health Plan and the pharmacy benefit managerOther: Multidisciplinary team interventionsOther: Multidisciplinary team bimonthly visits either in person or via telephone.
- First Posted Date
- 2009-11-17
- Last Posted Date
- 2010-01-21
- Lead Sponsor
- Medco Health Solutions, Inc.
- Target Recruit Count
- 2150
- Registration Number
- NCT01014884
Genotype Guided Comparison of Clopidogrel and Prasugrel Outcomes Study
Terminated
- Conditions
- Cardiovascular Disease
- First Posted Date
- 2009-10-15
- Last Posted Date
- 2012-05-30
- Lead Sponsor
- Medco Health Solutions, Inc.
- Target Recruit Count
- 4471
- Registration Number
- NCT00995514
- Locations
- 🇺🇸
Medco Health Solutions, Inc, Franklin Lakes, New Jersey, United States
The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer
Completed
- Conditions
- Breast NeoplasmsTamoxifen
- Interventions
- Other: Poor Metabolism Status Follow Up Therapy ConsiderationsOther: CYP2D6 Inhibiting Drugs
- First Posted Date
- 2009-01-28
- Last Posted Date
- 2009-10-14
- Lead Sponsor
- Medco Health Solutions, Inc.
- Target Recruit Count
- 184
- Registration Number
- NCT00830973
- Locations
- 🇺🇸
Robert Epstein, Franklin Lakes, New Jersey, United States
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
Completed
- Conditions
- Embolism and ThrombosisEmbolismVascular DiseasesVenous ThromboembolismThrombosisThromboembolismWarfarin
- Interventions
- Other: CYP 2C9 and VKORC1 Testing for Warfarin
- First Posted Date
- 2009-01-28
- Last Posted Date
- 2010-11-16
- Lead Sponsor
- Medco Health Solutions, Inc.
- Target Recruit Count
- 1635
- Registration Number
- NCT00830570
- Locations
- 🇺🇸
Medco Health Solutions, Inc., Franklin Lakes, New Jersey, United States